Serial Number | 86859703 |
Word Mark | HEALTH NUCLEUS |
Filing Date | Monday, December 28, 2015 |
Status | 700 - REGISTERED |
Status Date | Tuesday, February 4, 2020 |
Registration Number | 5974700 |
Registration Date | Tuesday, February 4, 2020 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 19, 2019 |
Goods and Services | genetic testing of humans for medical diagnostic purposes; consulting services in the fields of diagnostic medical testing; DNA screening for medical purposes; genetic counseling; medical assistance consultancy provided by doctors and other specialized medical personnel; medical assistance consultancy provided by genomics and genetics experts; medical assistance services in the nature of genetic and medical information provided to medical professionals from remote locations via the internet and global computer networks through the use of archived genome sequence information, medical images, diagnostic test results, and a data storage and retrieval system; medical genetic testing consultations provided via phone, online chat or videoconferencing; medical diagnostic testing, monitoring and reporting services; medical imaging services; medical information; medical screening; medical testing for diagnostic purposes; medical testing of blood, saliva, stool; multi-disciplinary, integrative, genetic consultations for medical treatment purposes; providing a web site featuring genetic and medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing medical information; providing medical information, consultancy and advisory services; providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms, concerns, genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; providing medical testing and medical consultations to individuals and their physicians to help them make health, wellness and nutritional changes in their daily living to improve health; providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms based on genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; provision of health care and medical services by health care professionals via the internet or telecommunication networks; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; health assessment services, namely, providing assessment of risk of disease and providing health monitoring of individuals all through use of genome sequencing analysis and reporting, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; all for medical treatment and diagnostic purposes |
Disclaimer with Predetermined Text | "HEALTH" |
Goods and Services | scientific research services in the field of genomics and advanced clinical imaging to be used for personalized health; research and development in the field of genome sequencing and genome analysis; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment, and preparing related information reports therefor; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment from information obtained through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammography, and echocardiogram services, and preparing related information reports therefor; providing online searchable databases in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping, molecular analytics, patient scientific and medical information, genealogical information, advanced clinical imaging, health risk assessment for scientific research purposes; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, all in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, and health risk assessment; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment, and genealogical information; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment from information obtained through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammography, and echocardiogram services, and genealogical information; medical research; scientific investigations for medical purposes; medical and scientific research in the field of medical imaging; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research in the field of genome sequence analysis and genome sequence reporting for research purposes, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; research and development in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; scientific research for medical purposes in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; genetic testing of humans for scientific research purposes; all for scientific research purposes |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 7, 2016 |
Primary Code | 042 |
First Use Anywhere Date | Monday, August 31, 2015 |
First Use In Commerce Date | Monday, October 12, 2015 |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, January 7, 2016 |
Primary Code | 044 |
First Use Anywhere Date | Monday, August 31, 2015 |
First Use In Commerce Date | Monday, October 12, 2015 |
Party Name | HLI Nucleus Holdings, LLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | SAN DIEGO, CA 92121 |
Party Name | HLI Nucleus Holdings, LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | San Diego, CA 92121 |
Party Name | HLI Nucleus Holdings, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | San Diego, CA 92121 |
Event Date | Event Description |
Tuesday, April 18, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, April 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, April 18, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Tuesday, April 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, April 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, April 18, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, February 4, 2020 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, November 19, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 19, 2019 | PUBLISHED FOR OPPOSITION |
Wednesday, October 30, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, October 10, 2019 | EXPARTE APPEAL TERMINATED |
Thursday, October 10, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, October 3, 2019 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Wednesday, September 4, 2019 | REPLY BRIEF FILED - CHECK TTAB FILES |
Tuesday, August 13, 2019 | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED |
Tuesday, August 13, 2019 | EXAMINERS STATEMENT E-MAILED |
Tuesday, August 13, 2019 | EXAMINERS STATEMENT - COMPLETED |
Tuesday, July 23, 2019 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Thursday, July 18, 2019 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
Thursday, July 18, 2019 | ACTION DENYING REQ FOR RECON E-MAILED |
Thursday, July 18, 2019 | ACTION CONTINUING FINAL - COMPLETED |
Thursday, June 20, 2019 | ASSIGNED TO EXAMINER |
Wednesday, June 12, 2019 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
Tuesday, June 12, 2018 | EX PARTE APPEAL-INSTITUTED |
Tuesday, June 12, 2018 | EXPARTE APPEAL RECEIVED AT TTAB |
Wednesday, December 13, 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, December 13, 2017 | FINAL REFUSAL E-MAILED |
Wednesday, December 13, 2017 | FINAL REFUSAL WRITTEN |
Tuesday, November 21, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, November 20, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, November 21, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, November 21, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, November 20, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, May 19, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, May 19, 2017 | NON-FINAL ACTION E-MAILED |
Friday, May 19, 2017 | NON-FINAL ACTION WRITTEN |
Tuesday, May 9, 2017 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
Tuesday, May 9, 2017 | ASSIGNED TO LIE |
Tuesday, November 1, 2016 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, November 1, 2016 | LETTER OF SUSPENSION E-MAILED |
Tuesday, November 1, 2016 | SUSPENSION LETTER WRITTEN |
Wednesday, October 19, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 19, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, October 19, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, April 19, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 19, 2016 | NON-FINAL ACTION E-MAILED |
Tuesday, April 19, 2016 | NON-FINAL ACTION WRITTEN |
Tuesday, April 12, 2016 | ASSIGNED TO EXAMINER |
Thursday, January 7, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, December 31, 2015 | NEW APPLICATION ENTERED |